Top compounds associated with response to SNX20


Feature Type Standardized
Nominal ANOVA
mRNA linifanib GDSC1000 pan-cancer AAC 0.24 1e-08
mRNA VNLG/124 GDSC1000 pan-cancer AAC 0.22 2e-08
mRNA CAY10576 CTRPv2 pan-cancer AAC 0.27 2e-08
mRNA Ki8751 CTRPv2 pan-cancer AAC 0.25 2e-08
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.23 5e-08
mRNA Bexarotene CTRPv2 pan-cancer AAC 0.24 6e-08
mRNA CD-1530 CTRPv2 pan-cancer AAC 0.25 6e-08
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.23 1e-07
mRNA AZD7762 CTRPv2 pan-cancer AAC 0.21 1e-07
mRNA MGCD-265 CTRPv2 pan-cancer AAC 0.22 3e-07
Download CSV